Difficulty: Medium
Average Score: 93%
Practice
A 10-mo-old boy has a left suprarenal mass. Surgery is accomplished with complete removal of the mass as well as the non-adherent lymph nodes; surgical biopsies are taken during surgery. The histology reveals poorly differentiated neuroblastoma with microscopic ipsilateral lymph nodes involvement. The contralateral lymph nodes are negative. Of the following, the BEST therapeutic approach for this infant is
Correct answer
A
Rationale
The best therapeutic approach for the 10-month-old boy with poorly differentiated neuroblastoma and ipsilateral lymph node involvement is chemotherapy (Option A).
Chemotherapy is the preferred initial treatment for neuroblastoma in infants due to their age and the aggressive nature of the cancer. It helps to shrink the tumor, control its spread, and target any cancer cells that may have spread beyond the primary tumor site. In this case, the presence of lymph node involvement indicates a need for systemic treatment like chemotherapy to target any potential metastases.
Radiotherapy (Option B) is generally not the first-line treatment for neuroblastoma in infants due to the potential long-term side effects on developing tissues and organs. Concomitant chemo-radiotherapy (Option C) may be too aggressive for an infant and can lead to severe toxicities. Chemotherapy followed by radiotherapy (Option D) is also not the best approach initially, as chemotherapy alone is often effective in treating neuroblastoma in infants.
In an educational context, it is crucial to understand the rationale behind treatment choices in pediatric oncology. Considering the age, stage, and specific characteristics of the tumor are essential factors in determining the most appropriate therapy to achieve the best outcomes while minimizing potential long-term side effects.
Chemotherapy is the preferred initial treatment for neuroblastoma in infants due to their age and the aggressive nature of the cancer. It helps to shrink the tumor, control its spread, and target any cancer cells that may have spread beyond the primary tumor site. In this case, the presence of lymph node involvement indicates a need for systemic treatment like chemotherapy to target any potential metastases.
Radiotherapy (Option B) is generally not the first-line treatment for neuroblastoma in infants due to the potential long-term side effects on developing tissues and organs. Concomitant chemo-radiotherapy (Option C) may be too aggressive for an infant and can lead to severe toxicities. Chemotherapy followed by radiotherapy (Option D) is also not the best approach initially, as chemotherapy alone is often effective in treating neuroblastoma in infants.
In an educational context, it is crucial to understand the rationale behind treatment choices in pediatric oncology. Considering the age, stage, and specific characteristics of the tumor are essential factors in determining the most appropriate therapy to achieve the best outcomes while minimizing potential long-term side effects.